EASD 2018 | Neue EASD/ADA−Empfehlungen: Therapie weiter personalisieren | Diabetes Forum
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care - Media Centre | EASD
Implications for treatment guidelines and future directions - Media Centre | EASD
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
ADA 2022 Highlights Slidekit
ADA/EASD-Konsensus-Papier schärft den Blick auf die Begleiterkrankungen
ADA-EASD Position Statement: Management of Hyperglycemia in T2DM, Part 4 of 4
ADA/EASD Consensus Report update 2022: What's new? - DiabetesontheNet
EASD 2022: Updated ADA/EASD type 2 diabetes consensus published - DiabetesontheNet
ADA-EASD-2022 | Cardio-Renal-Metabolic (CRM)
ADA 2022 Highlights Slidekit
EASD 2022: Updated ADA/EASD type 2 diabetes consensus published - DiabetesontheNet
ADA, EASD Issue New Recommendations for Type 2 Diabetes - MPR
Typ-1-Diabetes: Auch Erwachsene erkranken
Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE - ScienceDirect
Consenso ADA-EASD tratamiento diabetes tipo 2, resultados del estudio TANDEM, y más… | Servicio de Medicina Interna del Hospital de León
Outcome-Studien weisen neue Wege: Aktueller Status des ADA/EASD-Konsensus-Dokuments vorgestellt
ADA/EASD consensus update on management of hyperglycaemia in type 2 diabetes – report published in Diabetologia and Diabetes Care – Diabetologia
Management Diabetes mellitus Typ 1 – Consensus Report von ADA/EASD - Diabetologie & Endokrinologie - Universimed - Medizin im Fokus
EASD 2018 | Neue EASD/ADA−Empfehlungen: Therapie weiter personalisieren | Diabetes Forum
EASD 2022: Neuer transatlantischer Konsens zum Hyperglykämie-Management | Gelbe Liste
Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care - Media Centre | EASD
Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Diabetologia
